Go Back

Literature in Oncology: Urological Tumours (excluding prostate)

Fuccio C, Spinapolice EG, Cavalli C, Palumbo R, D'Ambrosio D, Trifirò G.

18F-Fluoride PET/CT in the detection of bone metastases in clear cell renal cell carcinoma: discordance with bone scintigraphy.

Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1930-1.


Makis W, Ciarallo A, Rakheja R, Probst S, Hickeson M, Rush C, Novales-Diaz JA, Derbekyan V, Stern J, Lisbona R.

Spectrum of malignant renal and urinary bladder tumors on 18F-FDG PET/CT: a pictorial essay.

Clin Imaging. 2012 Nov-Dec;36(6):660-73.


Grassi I, Nanni C, Allegri V, Morigi JJ, Montini GC, Castellucci P, Fanti S.

The clinical use of PET with (11)C-acetate.

Am J Nucl Med Mol Imaging. 2012;2(1):33-47..


PDFFree pdf

Dierickx LO, Huyghe E, Nogueira D, Zerdoud S, Filleron T, Brillouet S, Delauney B, Montagut J, Bujan L, Plante P, Courbon F.

Functional testicular evaluation using PET/CT with 18F-fluorodeoxyglucose.

Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):129-37.


Rioja J, Rodríguez-Fraile M, Lima-Favaretto R, Rincón-Mayans A, Peñuelas-Sánchez I, Zudaire-Bergera JJ, Parra RO.

Role of positron emission tomography in urological oncology.

BJU Int. 2010 Dec;106(11):1578-93.


Mueller-Lisse UG, Mueller-Lisse UL.

Imaging of advanced renal cell carcinoma.

World J Urol. 2010 Jun;28(3):253-61.


Avril N, Dambha F, Murray I, Shamash J, Powles T, Sahdev A.

The clinical advances of fluorine-2-D-deoxyglucose--positron emission tomography/computed tomography in urological cancers.

Int J Urol. 2010 Jun;17(6):501-11. doi: 10.1111/j.1442-2042.2010.02509.x. Epub 2010 Apr 1. Review.